1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
IRadimed Corporation

IRadimed Corporation

IRMD
IRadimed CorporationUS flagNASDAQ Capital Market
83.45
USD
-3.14
- -
1.07BMarket Cap

Total Valuation

IRadimed Corporation carries a market capitalization of 1.07B, placing it among publicly traded companies globally. Its enterprise value stands at 1.16B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.07B
Enterprise Value1.16B

Share Statistics

IRadimed Corporation currently has 12.79M shares outstanding.

Shares Outstanding12.79M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

IRadimed Corporation trades at a trailing price-to-earnings ratio of 52.87. The price-to-sales ratio is 14.12, and the price-to-book ratio stands at 12.01.

PE Ratio52.87
PS Ratio14.12
PB Ratio12.01
P/TBV Ratio12.43
P/FCF Ratio42.18
P/OCF Ratio44.92

Enterprise Valuation

On an enterprise value basis, IRadimed Corporation trades at an EV/EBITDA multiple of 39.84 and an EV/FCF ratio of 39.88. The EV/Sales ratio of 13.47 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 42.20 provides insight into valuation relative to core operating earnings.

EV / Sales13.47
EV / EBITDA39.84
EV / EBIT42.20
EV / FCF39.88

Financial Position

IRadimed Corporation maintains a current ratio of 9.46, meaning it holds 9.5x the short-term assets needed to cover near-term liabilities.

Current Ratio9.46
Quick Ratio7.89
Debt / EquityN/A
Debt / EBITDAN/A
Interest CoverageN/A

Financial Efficiency

IRadimed Corporation posts a return on equity of 23.52 and a return on invested capital of 21.73.

Return on Equity (ROE)23.52
Return on Assets (ROA)20.82
Return on Invested Capital (ROIC)21.73
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.78

Taxes

Over the trailing twelve months, IRadimed Corporation has paid 6.69M in income taxes, reflecting an effective tax rate of 22.49.

Income Tax6.69M
Effective Tax Rate22.49

Stock Price Statistics

IRadimed Corporation's stock has gained approximately 16.14475% over the past 52 weeks. The 50-day moving average sits at 92.06, while the 200-day moving average is 94.48.

Beta (5Y)N/A
52-Week Price Change16.14475%
50-Day Moving Average92.06
200-Day Moving Average94.48
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, IRadimed Corporation generated 86.34M in revenue and converted that into 23.05M in net income, yielding earnings per share of 1.79. EBITDA reached 29.18M, while operating income came in at 27.56M.

Revenue86.34M
Gross Profit65.50M
Operating Income27.56M
Pretax Income29.75M
Net Income23.05M
EBITDA29.18M
EBIT27.56M
Earnings Per Share (EPS)1.79

Balance Sheet

Total book value stands at 101.75M, with working capital of 77.56M providing operational flexibility.

Cash & Cash Equivalents59.08M
Total DebtN/A
Net Debt-59.08M
Equity (Book Value)101.75M
Book Value Per Share7.96
Working Capital77.56M

Cash Flow

IRadimed Corporation produced 27.14M in operating cash flow over the past twelve months. After subtracting -2.02M in capital expenditures, free cash flow totaled 25.12M - equivalent to 1.97 per share.

Operating Cash Flow27.14M
Capital Expenditures-2.02M
Free Cash Flow25.12M
FCF Per Share1.97

Margins

IRadimed Corporation operates with a gross margin of 75.86, reflecting its pricing power and cost economics. The operating margin of 31.92 and net profit margin of 26.70 provide insight into operational efficiency.

Gross Margin75.86
Operating Margin31.92
Pretax Margin34.45
Profit Margin26.70
EBITDA Margin33.80

Dividends & Yields

The company's payout ratio of 68.66 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share1.24
Dividend YieldN/A
Payout Ratio68.66
Shareholder Yield1.51
FCF Yield2.37

Scores

IRadimed Corporation posts an Altman Z-Score of 58.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score58.73